Open Access. Powered by Scholars. Published by Universities.®

Antitrust and Trade Regulation Commons™

Open Access. Powered by Scholars. Published by Universities.®

7,239 Full-Text Articles 5,540 Authors 5,142,799 Downloads 137 Institutions

All Articles in Antitrust and Trade Regulation

Faceted Search

7,239 full-text articles. Page 209 of 209.

When The Wto Works, And How It Fails, Anu Bradford 2010 Columbia Law School

When The Wto Works, And How It Fails, Anu Bradford

Faculty Scholarship

This Article seeks to explain when an international legal framework like the WTO can facilitate international cooperation and when it fails to do so. Using an empirical inquiry into different agreements that the WTO has attempted to facilitate — specifically, intellectual property and antitrust regulation — it reveals more general principles about why the WTO can facilitate agreement in some situations and not in others. Comparing the successful conclusion of the TRIPS Agreement and the failed attempts to negotiate a WTO antitrust agreement indicates that international cooperation is likely to emerge when the interests of powerful states align and when …


Pharmaceutical Patent Litigation Settlements: Implications For Competition And Innovation, John R. Thomas 2010 Georgetown University Law Center

Pharmaceutical Patent Litigation Settlements: Implications For Competition And Innovation, John R. Thomas

Georgetown Law Faculty Publications and Other Works

Although brand-name pharmaceutical companies routinely procure patents on their innovative medications, such rights are not self-enforcing. Brand-name firms that wish to enforce their patents against generic competitors must commence litigation in the federal courts. Such litigation ordinarily terminates in either a judgment of infringement, which typically blocks generic competition until such time as the patent expires, or a judgment that the patent is invalid or not infringed, which typically opens the market to generic entry. As with other sorts of commercial litigation, however, the parties to pharmaceutical patent litigation may choose to settle their case. Certain of these settlements have …


Digital Commons powered by bepress